These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6365800)

  • 41. Expression of normal and tumor-associated antigens in human breast carcinoma.
    Sawtell NM; DiPersio L; Michael JG; Pesce AJ; Weiss MA
    Lab Invest; 1984 Aug; 51(2):225-32. PubMed ID: 6087025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival in breast cancer related to tumour oestrogen receptor status and immunohistochemical staining for NCRC 11.
    Angus B; Napier J; Purvis J; Ellis IO; Hawkins RA; Carpenter F; Horne CH
    J Pathol; 1986 Aug; 149(4):301-6. PubMed ID: 3020217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance].
    Beckmann MW; Tutschek B; Göhring UJ; Engels K; Picard FK; Scharl A; Niederacher D; Schnürch HG
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):258-65. PubMed ID: 7607382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Murine mammary tumor virus related antigen in human male mammary carcinoma.
    Lloyd RV; Rosen PP; Sarkar NH; Jimenez D; Kinne DW; Menendez-Botet C; Schwartz MK
    Cancer; 1983 Feb; 51(4):654-61. PubMed ID: 6295611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of epithelial membrane antigen expression in human mammary epithelium by ultrastructural immunoperoxidase cytochemistry.
    Petersen OW; van Deurs B
    J Histochem Cytochem; 1986 Jun; 34(6):801-9. PubMed ID: 3009605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator.
    Ellis IO; Hinton CP; MacNay J; Elston CW; Robins A; Owainati AA; Blamey RW; Baldwin RW; Ferry B
    Br Med J (Clin Res Ed); 1985 Mar; 290(6472):881-3. PubMed ID: 3919829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study.
    Ostrowski JL; Sawan A; Henry L; Wright C; Henry JA; Hennessy C; Lennard TJ; Angus B; Horne CH
    J Pathol; 1991 May; 164(1):75-81. PubMed ID: 2056391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule.
    Ceriani RL; Peterson JA; Lee JY; Moncada R; Blank EW
    Somatic Cell Genet; 1983 Jul; 9(4):415-27. PubMed ID: 6353626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma.
    Ellis IO; Bell J; Todd JM; Williams M; Dowle C; Robins AR; Elston CW; Blamey RW; Baldwin RW
    Br J Cancer; 1987 Sep; 56(3):295-9. PubMed ID: 3663477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue.
    Heyderman E; Steele K; Ormerod MG
    J Clin Pathol; 1979 Jan; 32(1):35-9. PubMed ID: 372248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers.
    Arklie J; Taylor-Papadimitrious J; Bodmer W; Egan M; Millis R
    Int J Cancer; 1981 Jul; 28(1):23-9. PubMed ID: 6273328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4.
    Pancino G; Osinaga E; Charpin C; Mistro D; Barque JP; Roseto A
    Br J Cancer; 1991 Mar; 63(3):390-8. PubMed ID: 1706194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells.
    Griffiths AB; Burchell J; Gendler S; Lewis A; Blight K; Tilly R; Taylor-Papadimitriou J
    Int J Cancer; 1987 Sep; 40(3):319-27. PubMed ID: 3623715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.
    Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS
    Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimal breast cancer: analysis of proliferative activity using a monoclonal antibody to proliferating cell nuclear antigen (PCNA) and its relationship to histological grade and prognosis.
    Lanzafame S; Magro G; Broggi B
    Pathologica; 1994 Apr; 86(2):150-6. PubMed ID: 7936757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.
    Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L
    Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paget's disease of the nipple. Immunohistochemical localization of milk fat globule membrane antigens.
    Kirkham N; Berry N; Jones DB; Taylor-Papadimitriou J
    Cancer; 1985 Apr; 55(7):1510-2. PubMed ID: 2983857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of immunohistochemical parameters in breast carcinomas.
    Wrba F; Reiner A; Markis-Ritzinger E; Holzner JH; Reiner G; Spona J
    Pathol Res Pract; 1988 Jun; 183(3):277-83. PubMed ID: 2843841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.